A novel anti-vascular therapy for cancer.
Folkman
Judah
J
Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. judah.folkman@tch.harvard.edu
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D001427:Bacterial Toxins / Q000494:pharmacology*; D003013:Clostridium / Q000472:pathogenicity; D004195:Disease Models, Animal; D051379:Mice; D008870:Microtubules / Q000378:metabolism; D009336:Necrosis; D009369:Neoplasms / Q000098:blood supply / Q000628:therapy; D009389:Neovascularization, Pathologic; D013170:Spores
D020533:Angiogenesis Inhibitors; D001427:Bacterial Toxins; C075216:Clostridium novyi alpha-toxin